Cargando…

Nectin-4 inhibitors: An ace up our sleeve against advanced urothelial carcinoma

Detalles Bibliográficos
Autor principal:	Kumaraswamy, Santosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Uroscan
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555568/ https://www.ncbi.nlm.nih.gov/pubmed/34759533 http://dx.doi.org/10.4103/iju.iju_206_21

Ejemplares similares

First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
por: Kumaraswamy, Santosh
Publicado: (2021)

Pharmacological prophylaxis for venous thromboembolism: Is it time to change the gold standard?
por: Kumaraswamy, Santosh
Publicado: (2021)

POUT trial: Perioperative chemotherapy in upper tract urothelial carcinoma – A standard of care?
por: Ranjan, Satish Kumar
Publicado: (2020)

Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma?
por: Kumar, Naveen
Publicado: (2021)

Role of atezolizumab therapy combined with platinum-based chemotherapy in untreated metastatic urothelial carcinoma – The new landscapes (IMvigor130 trial)
por: Misra, Ankit
Publicado: (2021)

Role of simultaneous fine needle aspiration cytology of palpable inguinal lymph node and primary tumor biopsy in carcinoma of the penis
por: Khattar, Nikhil, et al.
Publicado: (2007)

CheckMate 214 trial: Immune checkpoint regulators for advanced renal cell carcinoma
por: Jena, Rahul
Publicado: (2020)

Long-term follow-up results of nivolumab plus cabozantinib versus sunitinib for advanced renal cell cancer: Checkmate 9ER trial
por: Tarigopula, Vivek
Publicado: (2022)

Temsirolimus, interferon alfa or both in advanced renal-cell carcinoma: One plus one does not always equal two
por: Grover, S., et al.
Publicado: (2007)

Follow-up after pyeloplasty: How long?
por: Nirmal, T. J., et al.
Publicado: (2008)

Does antenatal pelvic floor muscle training prevent stress urinary incontinence in primi-gravidae?
por: Gupta, Gaurav, et al.
Publicado: (2009)

Can micturating cystourethrograms be avoided in follow-up of antenatally diagnosed hydronephrosis?
por: Chawla, Arun, et al.
Publicado: (2008)

Endocrine treatment in advanced prostate cancer: When to start?
por: Choudhrie, A. V., et al.
Publicado: (2009)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

Open versus robotic radical cystectomy: Results from the 3-year follow-up of the RAZOR trial
por: Nagasubramanian, Santhosh
Publicado: (2020)

PROpel trial: Are PARP inhibitors ready to become the first-line treatment for mCRPC?
por: Gaur, Abhay Singh
Publicado: (2022)

KEYNOTE-564: Adjuvant immunotherapy for renal cell carcinoma
por: Pandey, Abhishek
Publicado: (2022)

The role of 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: Is it the new beginning
por: Agrawal, Sumit
Publicado: (2020)

PROFOUND trial –a new era in targeted therapeutics for prostate carcinoma
por: Tosh, Jyoti Mohan
Publicado: (2022)

What is the role of adjuvant chemotherapy in locally advanced and lymph node-positive bladder cancer after radical cystectomy?
por: Maheshwari, Ruchir, et al.
Publicado: (2009)

Apalutamide: A novel therapy for non metastatic castration-resistant carcinoma prostate
por: Jayasimha, Sudhindra
Publicado: (2018)

Comparison of multiparametric ultrasound versus multiparametric magnetic resonance imaging for diagnosis of carcinoma prostate: The CADMUS trial
por: Tarigopula, Vivek
Publicado: (2022)

Prognostic stratification of renal cell carcinoma using a pathological triad of microvascular invasion, Fuhrman's grade and tumor size
por: Prakash, Gagan, et al.
Publicado: (2007)

Intravesical real-time imaging and staging of bladder cancer: Use of optical coherence tomography
por: Sengottayan, Vengatesh K., et al.
Publicado: (2008)

Survival following primary androgen deprivation therapy among men with localized prostate cancer
por: Vasudeva, Pawan, et al.
Publicado: (2008)

Is lap nephrectomy superior to open? A randomized trial
por: Kumar, Anup, et al.
Publicado: (2008)

Risk factors for persistent stress urinary incontinence after mid-urethral procedures
por: Chawla, Arun, et al.
Publicado: (2008)

Botulinum toxin in high-risk BPH patients in retention
por: Reddy, Sreedhar, et al.
Publicado: (2008)

Combined dorsal plus ventral double buccal mucosa graft in bulbar urethral reconstruction
por: Chawla, Arun, et al.
Publicado: (2008)

Does tamsulosin facilitate expulsion of distal ureteric calculus following lithotripsy?
por: Gupta, Gaurav, et al.
Publicado: (2008)

Partial nephrectomy for small renal tumors may prevent chronic kidney disease
por: Kumar, Rajeev
Publicado: (2008)

Urethral reconstructive surgery: Which catheters are better?
por: Suryavanshi, Manav, et al.
Publicado: (2008)

Ureteroilleal anastomosis in orthotopic ileal neobladders: Does technique matter?
por: Gupta, Parag, et al.
Publicado: (2008)

Can tomato juice be used for prophylaxis in recurrent stone formers?
por: Agrawal, Madhu S., et al.
Publicado: (2009)

Antibiotic prophylaxis in vesicoureteral reflux: A paradigm shift
por: Banerji, J. S., et al.
Publicado: (2009)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
por: Vasudeva, Pawan, et al.
Publicado: (2008)

What is the treatment of choice for bulbar urethral strictures which are not an indication for visual internal urethrotomy?
por: Dubey, Deepak, et al.
Publicado: (2008)

Does early orchidopexy reduce risk of testicular cancer?
por: Banerji, John S., et al.
Publicado: (2008)

Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial
por: Dubey, Deepak, et al.
Publicado: (2008)

Optimizing bowel recovery after laparoscopic donor nephrectomy
por: Prakash, Gagan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_cqct6g48v6lv02veomu2vajcfg